| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.012 | 0.9 |